Retinoic acid |
tretinoin |
302-79-4 |
all-trans-Retinoic acid |
Vitamin A acid |
trans-Retinoic acid |
ATRA |
Retin-A |
Vesanoid |
Aberel |
Eudyna |
Renova |
Airol |
All-trans Retinoic Acid |
all-trans-Vitamin A acid |
Dermairol |
Aknoten |
Aknefug |
Cordes vas |
Epi-aberel |
TRETINON |
Tretin M |
Retin A |
Atralin |
all-trans-Vitamin A1 acid |
all-trans-Tretinoin |
Retionic acid |
All Trans Retinoic Acid |
Vitamin A1 acid, all-trans- |
Retin-A Micro |
beta-Retinoic acid |
all-(E)-Retinoic acid |
Vitamin A acid, all-trans- |
(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoic acid |
Retinoate |
Retinoic acid, all-trans- |
Alltrans-retinoic acid |
NSC-122758 |
Retacnyl |
Vesnaroid |
Ro 1-5488 |
Tretinoin, all-trans- |
all trans-Retinoic acid |
Stieva-A |
Tretinoine |
Solage |
all-trans-beta-Retinoic acid |
Effederm |
.beta.-Retinoic acid |
Kerlocal |
Oristar rna |
RETINOIC ACID, ALL TRANS |
Tretinoin/All-Trans Retinoic Acid |
Aberela Norway |
Avitoin Norway |
Effederm France |
A-Acido (Argentina) |
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid |
(all-E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid |
MLS000028588 |
b-Retinoic acid |
Retinoic acid (GMP) |
Tretinoine INN-French |
Tretinoinum INN-Latin |
AT-RA |
Tretinoina INN-Spanish |
Tretinoino INN-Spanish |
CHEMBL38 |
(2E,4E,6E,8E)-3,7-Dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)nona-2,4,6,8-tetraenoic acid |
2,4,6,8-Nonatetraenoic acid, 3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-, (all-E)- |
NSC122758 |
Atragen |
Retinova |
SMR000058245 |
(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid |
CHEBI:15367 |
15-Apo-beta-caroten-15-oic acid |
5688UTC01R |
Tretinoin (TN) |
beta-Ra |
Acnavit Denmark |
AGN 100335 |
REA |
9-cis-RA |
Retin A (TN) |
NCGC00017280-10 |
Tretinoinum |
Aberela |
Acnavit |
Avitoin |
Betarretin |
Tretinoina |
Tretinoino |
A-Vitaminsyre |
MFCD00001551 |
all-trans-b-Retinoic acid |
Cordes VAS Germany |
A-Vitaminsyre Denmark |
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ECL) |
trans-Retinoate |
beta-Retinoate |
tretinoine (French) (EINECS) |
cis-Retinoic acid |
Acide retinoique (French) (DSL) |
Refissa |
Nexret |
Vitamin a acid, trans- |
Retisol-A |
Acid A Vit (Belgium, Netherlands) |
3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)nona-2,4,6,8-tetraenoic acid |
3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2E,4E,6E,8E-tetraenoic acid |
(11Z)-retinoic acid |
(2E,4E,6E,8E)-3,7-Dimethyl-9-(2,6,6-trimethyl-cyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoic acid |
3HRetinoic acid |
Renova (TN) |
CCRIS 3294 |
Avita (TN) |
HSDB 2169 |
SR-01000000239 |
EINECS 206-129-0 |
NSC 122758 |
BRN 2057223 |
retinoicacid |
Tretinoin (JAN/USP/INN) |
Retinoic acid, cis-9,trans-13- |
Tretinion |
TNP00194 |
UNII-5688UTC01R |
BML2-E05 |
DTXSID7021239 |
1cbr |
3Htretinoin |
All-E-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid |
Tretinoin USAN:USP:INN:BAN |
CAS-302-79-4 |
Prestwick_424 |
all-(E)-Retinoate |
Tretinoine (French) |
ALTRENO |
Retinoic acid, cis- |
(5E)-Retinoic acid |
3HVitamin A acid |
1n4h |
CPD000058245 |
Retinoic acid all trans |
TRETINOIN INN |
TRETINOIN JAN |
6-s-trans-retinoic acid |
TRETINOIN HSDB |
TRETINOIN USAN |
Vitamin-A-sA currencyure |
Opera_ID_1055 |
Prestwick2_000257 |
Prestwick3_000257 |
Spectrum5_001746 |
Spectrum5_001933 |
TRETINOIN VANDF |
acide retinoique (French) |
Vesanoid (TN) (Roche) |
Tretinoin - Retinoic Acid |
bmse000562 |
TRETINOIN MART. |
UPCMLD-DP097 |
R 2625 |
Renova (0.02% cream) |
RETINOIC ACID MI |
SCHEMBL3145 |
TRETINOIN USP-RS |
TRETINOIN WHO-DD |
(9Z,13Z)-Retinoic acid |
3,7-Dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)nona-2,4,6,8-all-trans-tetraenoic acid |
Altreno (0.05% lotion) |
BIDD:PXR0081 |
Lopac0_001061 |
Avita (0.025% gel) |
BSPBio_000074 |
BSPBio_001500 |
RETINOIC ACID INCI |
MLS001076515 |
MLS002207234 |
MLS002222211 |
MLS002548861 |
MLS006010222 |
BIDD:GT0483 |
SPECTRUM1502016 |
9-cis-retinoic acid (9cRA) |
3HRA |
BPBio1_000082 |
cid_444795 |
GTPL2644 |
.beta.-all-trans-Retinoic acid |
TRETINOIN ORANGE BOOK |
ZIANA COMPONENT TRETINOIN |
all-trans-retinoic acid (ATRA) |
SCHEMBL19091395 |
TRETINOIN EP MONOGRAPH |
BDBM31883 |
HMS502N05 |
SOLAGE COMPONENT TRETINOIN |
TWYNEO COMPONENT TRETINOIN |
VELTIN COMPONENT TRETINOIN |
TRETINOIN USP MONOGRAPH |
BCPP000036 |
BDBM323588 |
HMS1361K22 |
HMS1568D16 |
HMS1791K22 |
HMS1921D14 |
HMS1989K22 |
HMS2089D20 |
HMS2092N11 |
HMS2095D16 |
HMS2236N03 |
HMS3259E11 |
HMS3263E04 |
HMS3402K22 |
HMS3411B09 |
HMS3675B09 |
HMS3712D16 |
Pharmakon1600-01502016 |
Retinoic acid, all-trans- (8CI) |
124510-04-9 |
2,4,6,8-Nonatetraenoic acid, 3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-, (2E,4E,6Z,8E)- |
ACT00012 |
BCP01405 |
TRETINOIN COMPONENT OF ZIANA |
TRI-LUMA COMPONENT TRETINOIN |
US10188615, at-RA |
Tox21_110812 |
Tox21_202330 |
Tox21_300305 |
Tox21_501061 |
TRETINOIN COMPONENT OF SOLAGE |
TRETINOIN COMPONENT OF TWYNEO |
TRETINOIN COMPONENT OF VELTIN |
All-trans Retinoic Acid (Tretinoin) |
CCG-39912 |
HY-14649G |
LMPR01090019 |
NSC759631 |
s1653 |
ZINC12358651 |
AKOS000280845 |
Tox21_110812_1 |
AC-6824 |
CS-1269 |
DB00755 |
GS-3578 |
LP01061 |
NC00481 |
NSC-759631 |
SDCCGSBI-0051031.P004 |
TRETINOIN COMPONENT OF TRI-LUMA |
IDI1_000903 |
IDI1_033970 |
NCGC00017280-05 |
NCGC00017280-06 |
NCGC00017280-07 |
NCGC00017280-08 |
NCGC00017280-09 |
NCGC00017280-12 |
NCGC00017280-15 |
NCGC00017280-16 |
NCGC00017280-17 |
NCGC00017280-18 |
NCGC00017280-19 |
NCGC00017280-20 |
NCGC00017280-23 |
NCGC00017280-38 |
NCGC00021808-04 |
NCGC00021808-05 |
NCGC00021808-06 |
NCGC00021808-07 |
NCGC00021808-09 |
NCGC00021808-11 |
NCGC00021808-14 |
NCGC00021808-15 |
NCGC00254179-01 |
NCGC00259879-01 |
NCGC00261746-01 |
BP-20401 |
BR164493 |
HY-14649 |
Retinoic acid, >=98% (HPLC), powder |
SBI-0051031.P003 |
CS-0626116 |
EU-0101061 |
ISOTRETINOIN IMPURITY A EP IMPURITY |
R0064 |
SW203749-4 |
02T794 |
C00777 |
D00094 |
Q29417 |
AB00052318-15 |
AB00052318-16 |
AB00052318-17 |
AB00052318_18 |
AB00052318_19 |
A899883 |
EN300-27107561 |
L000833 |
Q-200610 |
SR-01000000239-3 |
SR-01000000239-4 |
SR-01000000239-6 |
SR-01000000239-7 |
BRD-K06926592-001-01-7 |
BRD-K71879491-001-15-0 |
BRD-K71879491-001-22-6 |
SR-01000000239-12 |
SR-01000000239-13 |
SR-01000000239-14 |
SR-01000000239-15 |
WLN: L6UTJ A1 B1U1Y1&U2U1Y1&U1VQ C1 C1 |
Tretinoin, European Pharmacopoeia (EP) Reference Standard |
WLN: L6UTJ A1 B1U1Y1 & U2U1Y1 & U1VQ C1 C1 |
Tretinoin, United States Pharmacopeia (USP) Reference Standard |
3,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid |
Tretinoin, Pharmaceutical Secondary Standard; Certified Reference Material |
(2E,4E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)-2,4,6,8-nonatetraenoic acid |
(4E,6E,8E)-9-(2,6,6-Trimethyl-1-cyclohexenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic acid |
(8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoic acid |
(all-E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoate |
2,4,6,8-Nonatetranoic acid, 3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)- |
2,6,8-Nonatetranoic acid, 3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)- |
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoate |
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2E,4E,6E,8E,-nonatetraenoic acid |
all-trans-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic Acid |
2,4, 6,8-Nonatetranoic acid, 3,7-dimethyl-9-(2,6, 6-trimethyl-1-cyclohexen-1-yl)-, (2E, 4E, 6E, 8E)- |
2,4,6,8-Nonatetraenoic acid, 3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)--, (all trans)- |
2,4,6,8-Nonatetranoic acid, 3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-, (all trans)- |
2,6,8-Nonatetraenoic acid, 3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-, (all-E)- |
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid-, (all trans)- |
97950-17-9 |
|